Skip to main content
Equibles
RXST logo

RXST · RxSight, Inc. · Analyst Estimates

Track RXST — free

Use RXST with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RXST.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.82 -0.09 (-1.73%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$201.73M
Shares
41.59M
Volume · Oct 28 245.75K Avg daily vol (3M) 790.68K

Analyst Estimates

Compare analyst forecasts for RxSight, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-14 14:17 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.47
-0.28
-0.16
5
-0.27
-0.27
-0.27
-0.70
0
0
5
4
Revenue
USD
Publication date not stated
122.26M
147.06M
153.50M
10
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.32
-0.68
-0.26
5
-0.70
-0.70
-0.70
-0.56
3
2
2
2
Revenue
USD
Publication date not stated
136.60M
149.16M
173.43M
10
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.31
-0.19
0.09
5
-0.15
-0.15
-0.15
-0.17
3
3
2
1
Revenue
USD
Publication date not stated
25.10M
27.19M
29.26M
10
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.03
0.21
0.40
5
0.18
0.18
0.18
-0.15
1
0
4
4
Revenue
USD
Publication date not stated
29.00M
55.20M
61.05M
10
 — — — — — — — —
Key facts CIK 1111485 CUSIP 78349D107 13F (30d) 17 filings 17 filers Visit website Investor relations